Articles

 Innovation Challenge Finalist Bonbouton Inks Licensing Agreement with Stevens Institute of Technology

The partnership is aimed at bringing the company’s smart insole technology, which has the potential to detect diabetic foot ulcers, to market.

The Evolution of Real-World Evidence in Drug and Device Development

At the T1D Exchange annual meeting, two FDA officers discuss the changing regulatory landscape for drugs and devices.

At the T1D Exchange annual meeting, Wendy Wolf, PhD, discusses the successful launch of T1D Exchange Registry.

Data Will Fuel A New Era of Type 1 Diabetes Care, Says Endocrinologist

Speaking at the T1D Exchange annual meeting, Glooko Chief Medical Officer Dr. Mark Clements shares how un-siloed health data has the potential to reshape the care provided to people with type 1 diabetes.

Researchers have discovered that an increase of a particular type of microRNA in the bloodstream appears to herald the onset of type 1 diabetes.

-Kelsie LaFerriere The T1D Exchange Registry (hereon referred to as the Registry) is a research study designed to harness the power of people with type 1 diabetes. By completing a questionnaire once a year and opportunities to join other type 1 diabetes research, participants can add their voices, experiences, and data to a body of […]

JDRF and Beyond Type 1 Announce Alliance

The two largest advocacy organizations for people with type 1 diabetes will work closely together to amplify each other’s work and reduce overlap in their dual missions.

Why CGM May Be the Most Important Technology for People with Type 1 Diabetes

New research affirms the importance of CGM use in blood sugar management. We discuss the value of CGMs with Dr. Tomas Walker, the Senior Medical Director for Dexcom.

Check out a live stream of T1D Exchange’s Annual Meeting 2019 in Cambridge, MA: Live Stream The event has featured speakers from the FDA, faculty from our Quality Improvement Collaborative, and more. Join us online for insights, questions, and discussion panels!